Has healthcare embraced a hit-and-run strategy?
Sovaldi is off to the races — the biggest and most successful drug launch, by far, in the history of the industry. This is a truly remarkable achievement, a combination of derring-do and flawless execution that has given millions of patients the hope of a cure, and Gilead's investors the anticipation of a just reward. That blend of risk-taking and excellence is the hallmark of innovative drug companies, and the rare combination of skills that has given Gilead a $100 billion market cap within a short 27 years of its creation, making it the 8th biggest company in the industry.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063